Download PDF
Thromb Haemost 1999; 82(06): 1768
DOI: 10.1055/s-0037-1614912
Letters to the Editor
Schattauer GmbH

High Frequency of Factor V Leiden in a Population of Israeli Arabs

Ephraim Rosen
1   From the Department of Internal Medicine and Medical Genetics Laboratory, Shaare Zedek Medical Center, Hebrew University-Hadassah Medical School, Jerusalem, Israel
,
Paul Renbaum
1   From the Department of Internal Medicine and Medical Genetics Laboratory, Shaare Zedek Medical Center, Hebrew University-Hadassah Medical School, Jerusalem, Israel
,
Judith Heyd
1   From the Department of Internal Medicine and Medical Genetics Laboratory, Shaare Zedek Medical Center, Hebrew University-Hadassah Medical School, Jerusalem, Israel
,
Ephrat Levy-Lahad
1   From the Department of Internal Medicine and Medical Genetics Laboratory, Shaare Zedek Medical Center, Hebrew University-Hadassah Medical School, Jerusalem, Israel
› Author Affiliations
Further Information

Publication History

Received 17 March 1999

Accepted after revision 05 May 1999

Publication Date:
10 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
    CrossrefPubMedSearch in Google Scholar
  • 2 Dzimiri N, Meyer B. World distribution of factor V Leiden. Lancet 1996; 347: 481-2.
    PubMedSearch in Google Scholar
  • 3 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
    CrossrefPubMedSearch in Google Scholar
  • 4 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Veiden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
    CrossrefPubMedSearch in Google Scholar
  • 5 Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 1995; 10: 111-3.
    CrossrefPubMedSearch in Google Scholar
  • 6 Cox MJ, Rees DC, Martinson JJ, Clegg JB. Evidence for a single origin of factor V Leiden. Br J Haematol 1996; 92: 1022-5.
    CrossrefPubMedSearch in Google Scholar
  • 7 Gurgey A, Rustemov R, Parlak H, Balta G. Prevalence of Factor V Leiden and Methylenetetrahydroflate Reductase C677T Mutations in Azerbaijan. Thromb Haemost 1998; 80: 520-1.
    Thieme ConnectPubMedSearch in Google Scholar
  • 8 Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-7.
    CrossrefPubMedSearch in Google Scholar
  • 9 den Heijer M, Koster T, Blom HJ, Bos GMJ, Briët E, Reitsma PH, Vandenbroucke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deepvein thrombosis. N Engl J Med 1996; 334: 759-62.
    CrossrefPubMedSearch in Google Scholar